These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20870574)

  • 1. [Cystatin C and cardiovascular risk].
    Taglieri N; Koenig W; Kaski JC
    Ann Biol Clin (Paris); 2010; 68(5):517-29. PubMed ID: 20870574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C and cardiovascular risk.
    Taglieri N; Koenig W; Kaski JC
    Clin Chem; 2009 Nov; 55(11):1932-43. PubMed ID: 19713275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients.
    Lee SH; Park SA; Ko SH; Yim HW; Ahn YB; Yoon KH; Cha BY; Son HY; Kwon HS
    Metabolism; 2010 Feb; 59(2):241-6. PubMed ID: 19765773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study.
    Keller T; Messow CM; Lubos E; Nicaud V; Wild PS; Rupprecht HJ; Bickel C; Tzikas S; Peetz D; Lackner KJ; Tiret L; Münzel TF; Blankenberg S; Schnabel RB
    Eur Heart J; 2009 Feb; 30(3):314-20. PubMed ID: 19153178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
    J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C and the risk of death and cardiovascular events among elderly persons.
    Shlipak MG; Sarnak MJ; Katz R; Fried LF; Seliger SL; Newman AB; Siscovick DS; Stehman-Breen C
    N Engl J Med; 2005 May; 352(20):2049-60. PubMed ID: 15901858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum cystatin C is an independent predictor of cardiovascular events in people with relatively normal renal function.
    Meng L; Yang Y; Qi LT; Wang XJ; Xu GB; Zhang BW
    J Nephrol; 2012; 25(3):426-30. PubMed ID: 21928225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.
    Sato H; Kuroda T; Tanabe N; Ajiro J; Wada Y; Murakami S; Sakatsume M; Nakano M; Gejyo F
    Scand J Rheumatol; 2010; 39(1):33-7. PubMed ID: 20132068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of renal function in elderly patients.
    Fliser D
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):604-8. PubMed ID: 18941354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding estimated glomerular filtration rate: implications for identifying chronic kidney disease.
    Rule AD
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):242-9. PubMed ID: 17420668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
    Malyszko J; Bachorzewska-Gajewska H; Sitniewska E; Malyszko JS; Poniatowski B; Dobrzycki S
    Ren Fail; 2008; 30(6):625-8. PubMed ID: 18661413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on cystatin C: new insights into the importance of mild kidney dysfunction.
    Shlipak MG; Praught ML; Sarnak MJ
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):270-5. PubMed ID: 16609294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe obstructive sleep apnea increases cystatin C in clinically latent renal dysfunction.
    Kato K; Takata Y; Usui Y; Shiina K; Asano K; Hashimura Y; Saruhara H; Nishihata Y; Tomiyama H; Yamashina A
    Respir Med; 2011 Apr; 105(4):643-9. PubMed ID: 21183327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of various glomerular filtration rates estimating equations in patients with chronic kidney disease and diabetes.
    Li HX; Xu GB; Wang XJ; Zhang XC; Yang JM
    Chin Med J (Engl); 2010 Mar; 123(6):745-51. PubMed ID: 20368098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystatin C and blood pressure: results of 24 h ambulatory blood pressure monitoring.
    Mena C; Robles NR; de Prado JM; Gallego FG; Cidoncha A
    Eur J Intern Med; 2010 Jun; 21(3):185-90. PubMed ID: 20493420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C in acute heart failure without advanced renal impairment.
    Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
    Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is there a relationship between cystatin C and inflammatory status, oxidative stress and other cardiovascular risk factors in non-diabetic patients with chronic kidney disease?].
    Font R; Prats M; Gutiérrez C; Bardají A; Lalana M; Marsillach J; Camps J; Martínez Vea A
    Nefrologia; 2009; 29(3):228-35. PubMed ID: 19554056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cystatin C and microalbuminuria in the detection of vascular and renal damage in early stages.
    López Gómez JM; Sacristán Enciso B; Micó M; Arias Meneses F; de Sande Medel F; Alejo S
    Nefrologia; 2011; 31(5):560-6. PubMed ID: 21959722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure.
    Linzbach S; Samigullin A; Yilmaz S; Tsioga M; Zeiher AM; Spyridopoulos I
    Am J Cardiol; 2009 Apr; 103(8):1128-33. PubMed ID: 19361601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancies between creatinine-based and cystatin C-based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population.
    Delanaye P; Cavalier E; Saint-Remy A; Lutteri L; Krzesinski JM
    Scand J Clin Lab Invest; 2009; 69(3):344-9. PubMed ID: 19051098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.